Team

Board of Directors

Ali-Salanti_1_SH_600pix

Bio

Ali Salanti

Chief Executive Officer

Co-founder of VAR2 Pharma. Ali has a PhD in Medicine and is a Professor and Head of the Centre for Translational Medicine & Parasitology at the University of Copenhagen. Ali has authored over 150 scientific publications and 10 patent families, raised over €50M and launched 5 spinouts.
Mads_2_black and white_v2

Bio

Mads Daugaard

Executive Chairman of the Board

Co-founder of VAR2 Pharma. Mads has a PhD in Molecular Cancer Biology and is currently Head of the Molecular Pathology Unit at the Vancouver Prostate Centre and an Associate Professor at the University of British Columbia (Canada). Mads has authored over 60 scientific publications and 10 patent families, raised over €50M and launched 4 spinouts.
Thor-Theander_2_CC_600_pix

Bio

Thor G. Theander

Chief Medical Officer

Co-founder of VAR2 Pharma. Thor is an MD DSc. He is the Founder and former Head of the Center for Medical Parasitology at Univ. Copenhagen. Thor has authored over 300 scientific publications, co-founded 7 companies and raised over €100M. Thor has participated in the design and execution of over 10 phase I-III clinical trials, including the first licensed malaria vaccine.
Poul-Sorensen_1_CC_600_Pix

Bio

Poul Sorensen

Board Member

Co-founder of VAR2 Pharma. Poul is an MD PhD, board-certified anatomic pathologist and Professor at the University of British Columbia (Canada). Poul specializes in genetics and biology of pediatric cancers, has authored over 100 scientific publications, and raised over €50M.
Peter-Schröcksnadel_2_CC_600_pix

Bio

Peter Schröcksnadel

Board Member

Peter is a seasoned Austrian entrepreneur that founded and managed several companies. He joined the Board of VAR2 Pharma in 2016 and co-founded VarCT Diagnostics in 2017. He brings extensive business experience and vast networks from decades in the broadcasting/marketing industry and international alpine skiing organizations.

View Bio
Ali SalantiCEO

Co-founder of VAR2 Pharma. Ali has a PhD in Medicine and is a Professor and Head of the Centre for Translational Medicine & Parasitology at the University of Copenhagen. Ali has authored over 150 scientific publications and 10 patent families, raised over €50M and launched 5 spinouts.

View Bio
Mads DaugaardExecutive Chairman of the Board

Co-founder of VAR2 Pharma. Mads has a PhD in Molecular Cancer Biology and is currently Head of the Molecular Pathology Unit at the Vancouver Prostate Centre and an Associate Professor at the University of British Columbia (Canada). Mads has authored over 60 scientific publications and 10 patent families, raised over €50M and launched 4 spinouts.

View Bio
Thor G. TheanderChief Medical Officer

Co-founder of VAR2 Pharma. Thor is an MD DSc. He is the Founder and former Head of the Center for Medical Parasitology at Univ. Copenhagen. Thor has authored over 300 scientific publications, co-founded 7 companies and raised over €100M. Thor has participated in the design and execution of over 10 phase I-III clinical trials, including the first licensed malaria vaccine.

View Bio
Poul SorensenBoard Member

Co-founder of VAR2 Pharma. Poul is an MD PhD, board-certified anatomic pathologist and Professor at the University of British Columbia (Canada). Poul specializes in genetics and biology of pediatric cancers, has authored over 100 scientific publications, and raised over €50M.

View Bio
Peter SchröcksnadelBoard Member

Peter is a seasoned Austrian entrepreneur that founded and managed several companies. He joined the Board of VAR2 Pharma in 2016 and co-founded VarCT Diagnostics in 2017. He brings extensive business experience and vast networks from decades in the broadcasting/marketing industry and international alpine skiing organizations.

View Bio
Joseph RainerBoard Member

Team

Ali-Salanti_1_SH_600pix

Bio

Ali Salanti

Chief Executive Officer

Co-founder of VAR2 Pharma. Ali has a PhD in Medicine and is a Professor and Head of the Centre for Translational Medicine & Parasitology at the University of Copenhagen. Ali has authored over 150 scientific publications and 10 patent families, raised over €50M and launched 5 spinouts.
Dorte Holler Johansen_01_300dpi_black and white

Bio

Dorte Holler Johansen

Chief Financial Officer

Dorte has a MSc in Business Administration and over 20 years of business, financial and admin experience intersecting public-private sector in multiple companies. She has managed over 100 projects, incl. large, publicly funded multi-stakeholder consortia (incl. EU actions).
elena

Bio

Elena Vidal-Calvo​

Research Scientist​

Elena Vidal-Calvo has a PhD in Health and Medical Science (Clinical Cancer Research) and joined VAR2 Pharma in 2018. Elena has spent her PhD developing and characterizing Vartumabs and is now focused on understanding ofCS’s fundamental and clinical properties.
Picture1

Bio

Frederico M. Pimenta

Chief Operating Officer

Fred has a PhD in Chemistry and joined VAR2 Pharma in 2024. Before joining VAR2 Pharma, Fred worked as a consultant to deep-tech startups, advising on soft funding strategy and helping secure over €20M in non-dilutive funding by supporting grant applications with market research, competition analysis, drafting business plans and coordinating consortia.
Lara_black and white

Bio

Lara Duvnjak

PhD Fellow

Lara has a MSc in Health and Medical Science (Immunology and Inflammation) and joined VAR2 Pharma in 2022. Currently doing her PhD in Var2 Pharma, her work is primarily focused formulation and stability testing for ADCs, as well as designing and testing bispecific constructs.
Nader_black and white

Bio

Nader Al Nakouzi​

Senior Scientist - Preclinical Development

Nader al Nakouzi has a PhD in Cancer Biology and an MBA in Pharmaceutical Marketing. He joined VAR2 Pharma in 2016, bringing over 15 years of technical and scientific expertise in preclinical development, drug development, and cancer biology. Nader has directed multiple successful research programs, authored numerous scientific publications, and holds four international patents.
Robert Dagil_black and white

Bio

Robert Dagil

Senior Scientist - CMC Development

Robert Dagil has a PhD degree in the field of protein science and joined VAR2Pharma in 2017. Robert is leading the bispecific protein production team and brings technical and scientific expertise within protein engineering and CMC process development.
swati

Bio

Swati Choudhary​

Senior Scientist - CMC Development

Swati has a PhD in Biotechnology and joined VAR2 Pharma in 2016. She is leading the preclinical development of the ADC conjugate program including efficacy, localization and pharmacokinetics and preclinical tox studies. She also brings in expertise in potency assay development including ELISA based and in vitro cell based killing assays.
homas-Mandel-ClausenCC_600_pix

Thomas Clausen

Chief Technology Officer

Thor-Theander_2_CC_600_pix

Bio

Thor G. Theander

Chief Medical Officer

Co-founder of VAR2 Pharma. Thor is an MD DSc. He is the Founder and former Head of the Center for Medical Parasitology at Univ. Copenhagen. Thor has authored over 300 scientific publications, co-founded 7 companies and raised over €100M. Thor has participated in the design and execution of over 10 phase I-III clinical trials, including the first licensed malaria vaccine.
Tobias-Gustavsson_2_CC_600_pix

Tobias Gustavsson​

Director CMC Development​

Thomas Clausen

CTO

Tobias Gustavsson​

Director CMC Development​

Swati Choudhary​

Senior Scientist - CMC Development

Robert Dagil

Senior Scientist - CMC Development

View Bio
Dorte Holler JohansenChief Financial Officer

Dorte has an MBA in Economics and over 20 years of business, financial and admin experience intersecting public-private sector in multiple companies. She has managed over 100 projects, incl. large, publicly funded multi-stakeholder consortia (incl. EU actions).

Elena Vidal Calvo​

Research Scientist​

Nader Al Nakouzi​

Research Scientist

Chumpol Hueyploo

Lab Tech​

Frederico Pimenta

COO

The Board and Management

Ali Salanti

CEO Ali Salanti is founder and CEO of VAR2 Pharma. He holds a Ph.D. in medicine and is Professor at University of Copenhagen.

Mads Daugaard

Executive Chairman of the Board Dr. Mads Daugaard is co-founder and Executive Chairman of the Board of VarCT Diagnostics and VAR2 Pharma

Peter Schröcksnadel

Board Member Professor Peter Schröcksnadel joined the Board of VAR2 Pharma in 2016 and co-founded VarCT Diagnostics in 2017. He brings extensive business experience and vast networks from decades in in the broadcasting/marketing industry and international alpine skiing organisations.

Thor G. Theander

Chief Medical Officer Professor Thor Theander is co-founder and member of the Board of Directors of VAR2 Pharma. Thor has published more than 200 scientific publications and been involved in a large number of clinical trials. Thor was instrumental in the original discoveries leading to the development of the VAR2 technology and is today Chief Medical Officer in the company

Poul Sorensen

Board Member Professor Sorensen is co-founder and member of the Board of Directors of VAR2 Pharma. He is a molecular pathologist and cancer biologist, specializing in the genetics and biology of pediatric cancers.

Joseph Rainer

Board Member

The Team

Tobias Gustavsson

Director CMC Development

Robert Dagil

Senior Research Scientist
CMC Development

Thomas Mandel Clausen

Chief Technology Officer

Dorte Holler Johansen

Chief Financial Officer

Swati Choudhary

Senior Research Scientist
CMC Development

Joseph Rainer

Senior Research Scientist
Preclinical Development

Elena Vidal-Calvo

Research Scientist

Chumpol Hueyploo

Laboratory Technician

This website uses cookies.

Our website only uses strictly necessary cookies. Please consult our Privacy Policy for additional information on how we process your data.